Eugeni Saigí Grau

Suggest Changes
  • Citations Per Year
Learn More
AIM Advanced pancreatic cancer has a bad prognosis, with a median overall survival (OS) no longer than 4-6 months. Since the end of last century, monotherapy with gemcitabine has remained the(More)
  • 1